Carl Nathan
- Immunology top 0.01%
- Immune Response and Inflammation 43
- Immune cells in cancer 31
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 24
- Biochemistry top 0.01%
- Eicosanoids and Hypertension Pharmacology 23
- Physiology top 0.01%
- Nitric Oxide and Endothelin Effects 47
- Infectious Diseases top 0.05%
- Tuberculosis Research and Epidemiology 73
- Immunology and Allergy top 0.1%
-
- Mycobacterium research and diagnosis 38
-
- Biochemical and Molecular Research 34
- Co-authors
- Q W XieAihao DingDennis J. StuehrJohn D. MacMickingTed P. SzatrowskiHenry W. MurrayChristian BogdanYoram Vodovotz
- Cited by
- ImmunologyBiochemistryPhysiology
- Journals
- The Journal of Experimental Medicine (53 papers)Proceedings of the National Academy of Sciences (23 papers)The Journal of Immunology (16 papers)
- Partner nations
- United StatesChinaFrance
In The Last Decade
Carl Nathan
317 papers receiving 70.4k citations
Hit Papers
Peers
Comparison fields: 5 of 195
- Immunology 22.2k
- Biochemistry 6.1k
- Physiology 17.6k
- Infectious Diseases 8.2k
- Immunology and Allergy 2.5k
Countries citing papers authored by Carl Nathan
This map shows the geographic impact of Carl Nathan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl Nathan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl Nathan more than expected).
Fields of papers citing papers by Carl Nathan
This network shows the impact of papers produced by Carl Nathan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl Nathan. The network helps show where Carl Nathan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Carl Nathan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | Interferon- γ and infectious diseases: Lessons and prospectsbreakdown → | 2024 | 53 |
| 3 | 2021 | 36 | |
| 4 | 2021 | 18 | |
| 5 | 2021 | 5 | |
| 6 | 2020 | 124 | |
| 7 | 2020 | 76 | |
| 8 | 2018 | 57 | |
| 9 | 2017 | 87 | |
| 10 | 2017 | 45 | |
| 11 | Rational Design of Selective and Bioactive Inhibitors of the Mycobacterium Tuberculosis Proteasome | 2017 | 1 |
| 12 | 2016 | 2 | |
| 13 | 2016 | 6 | |
| 14 | 2013 | 72 | |
| 15 | 2005 | 10 | |
| 16 | 2003 | 415 | |
| 17 | 2003 | 123 | |
| 18 | 2003 | 332 | |
| 19 | 2003 | 346 | |
| 20 | 1967 | 1 |
About Carl Nathan
Carl Nathan is a scholar working on Biochemistry, Immunology and Infectious Diseases, having authored 318 papers that have together received 73.0k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (73 papers), Nitric Oxide and Endothelin Effects (47 papers), Immune Response and Inflammation (43 papers), Mycobacterium research and diagnosis (38 papers), Biochemical and Molecular Research (34 papers), Immune cells in cancer (31 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (24 papers) and Eicosanoids and Hypertension Pharmacology (23 papers). The work is most often cited by research in Immunology (22.2k citations), Biochemistry (6.1k citations) and Physiology (17.6k citations). Carl Nathan has collaborated with scholars based in United States, China and France. Frequent co-authors include Q W Xie, Aihao Ding, Dennis J. Stuehr, John D. MacMicking, Ted P. Szatrowski, Henry W. Murray, Christian Bogdan, Yoram Vodovotz, Zanvil A. Cohn and Yumiko Kashiwabara. Their work appears in journals such as The Journal of Experimental Medicine, Proceedings of the National Academy of Sciences, The Journal of Immunology, Journal of Clinical Investigation and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.